Carvana's Upbeat Q2 Revenue and bluebird bio's Bullish View Drive Momentum
- July 19th, 2023
- 344 views
Shares of Carvana Co. (NYSE: CVNA) experienced a significant surge of over 20% in pre-market trading following the company's announcement of its best quarter ever for adjusted EBITDA and total gross profit per unit.
Carvana reported second-quarter 2023 revenue of $2.97 billion, surpassing consensus estimates of $2.59 billion. Notably, the total gross profit per unit (GPU) showed an impressive year-over-year increase of 94%, reaching $6,520.
The company also revealed that its adjusted EBITDA for Q2 reached $155 million. Moreover, Carvana expressed confidence in achieving positive adjusted EBITDA for the second consecutive quarter in the third quarter of 2023.
$CVNA was trading at $48.00 in pre-market, up $8.20 (+20.60%).
In other news, BofA Securities has upgraded bluebird bio, Inc. (Nasdaq: BLUE) from Neutral to Buy and raised the price target from $6 to $10.
With $BLUE closing at $3.15 on Tuesday, the upgraded price target indicates a potential upside of $6.85 or approximately 217.46%, according to the financial advisory firm's view.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
Treasury Targets Family Members and Associates of Maduro Regime
December 20th, 2025Herbal Works Inc. Supports President Trump's Order Easing Restriction on Cannabis
December 18th, 2025Herbal Works Inc. Plans on Expansion of Product Line in 2026
December 18th, 2025December 17th, 2025Crown Equity Holdings Inc. Announces Changes to Board of Directors
December 16th, 2025
Member Login